Correlation Between Replimune and United Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Replimune and United Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Replimune and United Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Replimune Group and United Therapeutics, you can compare the effects of market volatilities on Replimune and United Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Replimune with a short position of United Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Replimune and United Therapeutics.

Diversification Opportunities for Replimune and United Therapeutics

0.5
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Replimune and United is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Replimune Group and United Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on United Therapeutics and Replimune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Replimune Group are associated (or correlated) with United Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of United Therapeutics has no effect on the direction of Replimune i.e., Replimune and United Therapeutics go up and down completely randomly.

Pair Corralation between Replimune and United Therapeutics

Given the investment horizon of 90 days Replimune Group is expected to generate 2.75 times more return on investment than United Therapeutics. However, Replimune is 2.75 times more volatile than United Therapeutics. It trades about 0.07 of its potential returns per unit of risk. United Therapeutics is currently generating about 0.1 per unit of risk. If you would invest  760.00  in Replimune Group on September 2, 2024 and sell it today you would earn a total of  648.00  from holding Replimune Group or generate 85.26% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Replimune Group  vs.  United Therapeutics

 Performance 
       Timeline  
Replimune Group 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Replimune Group are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting basic indicators, Replimune disclosed solid returns over the last few months and may actually be approaching a breakup point.
United Therapeutics 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in United Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable technical indicators, United Therapeutics is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Replimune and United Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Replimune and United Therapeutics

The main advantage of trading using opposite Replimune and United Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Replimune position performs unexpectedly, United Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in United Therapeutics will offset losses from the drop in United Therapeutics' long position.
The idea behind Replimune Group and United Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated